Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      JB Chemicals gets zero USFDA observations for Panoli unit

      JB Chemicals gets zero USFDA observations for Panoli unit

      Medical Dialogues Bureau7 July 2019 9:30 AM IST
      The US Food and Drug Administration (USFDA) has concluded inspection of company's newly set-up and commissioned solid oral dosage forms formulations...
      Oklahoma presses opioid case against JnJ

      Oklahoma presses opioid case against JnJ

      Medical Dialogues Bureau7 July 2019 9:00 AM IST
      While Hunter presses the claim that consumer products giant Johnson & Johnson (JnJ) is to blame for Oklahoma's opioid epidemic, he's also facing...
      GSK gets European nod for HIV drug Dovato

      GSK gets European nod for HIV drug Dovato

      Medical Dialogues Bureau6 July 2019 12:44 PM IST
      U.S: GlaxoSmithKline (GSK) recently said its specialist HIV company had received marketing authorisation from the European Commission for its drug to...
      SAARC nations favour India-based Haslab for Homoeopathic Medicines

      SAARC nations favour India-based Haslab for Homoeopathic Medicines

      Medical Dialogues Bureau6 July 2019 9:45 AM IST
      Haslab as they are known in the homoeopathy market, they provide various forms of homoeopathic products like eye drops, homoeopathic complex tablets,...
      Single dose of Xofluza flu drug as effective as Tamiflu in kids, says Roche

      Single dose of Xofluza flu drug as effective as Tamiflu in kids, says Roche

      Medical Dialogues Bureau6 July 2019 9:15 AM IST
      Xofluza, an oral treatment, was well tolerated in children, said Roche, whose medicine is already approved broadly in Japan and for people older than...
      Judge to reevaluate $80 million award in Monsanto cancer case

      Judge to reevaluate $80 million award in Monsanto cancer case

      Medical Dialogues Bureau6 July 2019 9:00 AM IST
      In March, a jury found that glyphosate, an active ingredient in Roundup, was a likely cause of 70-year-old Edwin Hardeman's diagnosis of non-Hodgkin's...
      Drugmakers cannot raise price of non-scheduled formulations by more than 10 pc yearly: Minister informs Parliament

      Drugmakers cannot raise price of non-scheduled formulations by more than 10 pc yearly: Minister informs Parliament

      Medical Dialogues Bureau5 July 2019 5:58 PM IST
      As per provisions of DPCO, all manufacturers of Scheduled medicines (branded or generic) have to sell their products within the ceiling price fixed by...
      Zydus Cadila gets USFDA nod for generic Misoprostol tablets to treat ulcers

      Zydus Cadila gets USFDA nod for generic Misoprostol tablets to treat ulcers

      Medical Dialogues Bureau5 July 2019 11:52 AM IST
      New Delhi: Drug firm Zydus Cadila Wednesday said it has received the final nod from the US health regulator to market its generic Misoprostol tablets...
      Elbrit Life Sciences to expand production capacity with over Rs 13 crore investment

      Elbrit Life Sciences to expand production capacity with over Rs 13 crore investment

      Medical Dialogues Bureau5 July 2019 9:45 AM IST
      Elbrit Life Sciences currently owns a manufacturing facility in Pondicherry with a capacity to manufacture 2 million units of solid dosage...
      Delhi High Court directs Centre to provide partial list of OTC drugs to doctors, pharmacists

      Delhi High Court directs Centre to provide partial list of OTC drugs to doctors, pharmacists

      Medical Dialogues Bureau5 July 2019 9:30 AM IST
      "As things stand today, it is not that difficult to provide a list of OTC drugs," the court said, directing that a "partial list" be provided to...
      Indian pharma industry to grow at 11-13 percent in FY2020, says rating agency Icra

      Indian pharma industry to grow at 11-13 percent in FY2020, says rating agency Icra

      Medical Dialogues Bureau5 July 2019 9:15 AM IST
      According to an Icra report covering a sample of 21 firms in the industry, the growth during FY2019 stood at around 12 per cent.NEW DELHI: Indian...
      Elizabeth Warren asks former USFDA chief Gottlieb to QUIT Pfizer board

      Elizabeth Warren asks former USFDA chief Gottlieb to QUIT Pfizer board

      Medical Dialogues Bureau5 July 2019 9:10 AM IST
      In a letter to Gottlieb, Warren, who is seeking the Democratic nomination for the 2020 presidential election, said "this kind of revolving door...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok